Cargando…
TCM therapies combined with chemotherapy for preventing recurrence and metastasis in postoperative II to IIIA NSCLC: A protocol for a systematic review and meta-analysis
BACKGROUND: Traditional Chinese Medicine (TCM) therapies have been combined with chemotherapy for preventing Recurrence and metastasis in postoperative II to IIIA non-small-cell lung cancer (NSCLC) and the associated better disease-free survival (DFS), but its effects remain elusive. The purpose of...
Autores principales: | Chen, Shuntai, Zhang, Zhenhua, Zhang, Xiwen, Qi, Runzhi, Jiang, Juling, Zhang, Xing, Xi, Yupeng, Liu, Rui, Guo, Qiujun, Zheng, Honggang, Hua, Baojin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6831319/ https://www.ncbi.nlm.nih.gov/pubmed/30817619 http://dx.doi.org/10.1097/MD.0000000000014724 |
Ejemplares similares
-
Study on the treatment of pancreatic cancer with integrated traditional Chinese and Western medicine: A study protocol of a multicenter prospective cohort study
por: Jiang, Juling, et al.
Publicado: (2019) -
Prognostic significance of E-cadherin expression in prostatic carcinoma: A protocol for systematic review and meta-analysis
por: Zhang, Xiwen, et al.
Publicado: (2020) -
Chinese herbal medicine for small cell lung cancer patients: A protocol for a systematic review and meta-analysis
por: Mi, Xue, et al.
Publicado: (2020) -
Taxane-based chemotherapy and risk of breast cancer-related lymphedema: Protocol for a systematic review and meta-analysis
por: Zhang, Zhenhua, et al.
Publicado: (2019) -
TCM monotherapy achieves significant efficacy in crizotinib-refractory advanced NSCLC with brain metastasis
por: Qin, Jiqiu, et al.
Publicado: (2023)